Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
25.8M
-
Shares change
-
+1.66M
-
Total reported value, excl. options
-
$434M
-
Value change
-
+$21.3M
-
Put/Call ratio
-
1.05
-
Number of buys
-
69
-
Number of sells
-
-33
-
Price
-
$16.78
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2017
136 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q2 2017.
Editas Medicine, Inc. - Common Stock (EDIT) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.8M shares
of 82.8M outstanding shares and own 31.21% of the company stock.
Largest 10 shareholders include FMR LLC (4.77M shares), Polaris Venture Management Co. VI, L.L.C. (2.8M shares), BlackRock Inc. (2.53M shares), VANGUARD GROUP INC (2.18M shares), Capital World Investors (1.77M shares), Viking Global Investors LP (1.71M shares), DEERFIELD MANAGEMENT CO (1.71M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.46M shares), EcoR1 Capital, LLC (717K shares), and STATE STREET CORP (538K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.